It was first revealed in vivo that membrane protein SLC7A11 can effectively reverse cardiomyopathy caused by ferritin deficiency by blocking ferroptosis in cardiomyocytes, which is expected to become a new target for the prevention and treatment of heart diseases [9]. Here, SLC7A11 is linked to heart disorder.